Sinovac Biotech Owners | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Sinovac Biotech Ltd.

Sinovac Biotech Ltd. | Ownership

Companies that own Sinovac Biotech Ltd.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

OrbiMed Advisors LLC

2,839,500

4.79%

0.21%

06/30/2018

Renaissance Technologies LLC

2,533,430

4.26%

-106,070

0.02%

06/30/2018

Neumann Advisory Hong Kong Ltd.

402,844

0.68%

1.65%

06/30/2018

SSgA Funds Management, Inc.

134,123

0.23%

-2,046

06/30/2018

Azimut Capital Management SGR SpA

132,153

0.22%

132,153

0.02%

06/30/2017

Sapphire Star Capital LLC

96,992

0.16%

96,992

0.65%

06/30/2018

DWS Investment GmbH

73,337

0.12%

-105,129

06/30/2018

The California Public Employees Retirement System

70,064

0.12%

-22,063

06/30/2018

Vericimetry Advisors LLC

68,292

0.12%

3,647

0.14%

07/31/2018

Yorktown Management & Research Co., Inc.

64,645

0.11%

64,645

0.09%

06/30/2018

About Sinovac Biotech

View Profile

Address	No. 15 Zhi Tong Road Beijing Beijing 102200 China
Employees	-
Website	http://www.sinovacbio.com
Updated	07/08/2019
Sinovac Biotech Ltd. is a holding and biopharmaceutical company, which engages in the research, development, manufacturing, and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease. It operates through the Mainland China and Hong Kong geographical segments. Its product pipelines include Healive, Bilive, Anflu, PANFLU.